Sutro Biopharma
STRO
STRO
114 hedge funds and large institutions have $241M invested in Sutro Biopharma in 2022 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
30% less capital invested
Capital invested by funds: $342M → $241M (-$101M)
30% less call options, than puts
Call options by funds: $727K | Put options by funds: $1.03M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
114
Holding in Top 10
1
Calls
$727K
Puts
$1.03M
Top Buyers
| 1 | +$10.2M | |
| 2 | +$5.07M | |
| 3 | +$4.75M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$4.69M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$3.78M |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$9.58M | |
| 3 | -$3.21M | |
| 4 |
Rafferty Asset Management
New York
|
-$1.35M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.28M |